Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation

Transplantation

Volumn 62, Issue 7, 1996, Pages 926-934

  Patel, Robin ^a   Portela, Daniel ^a   Badley, Andrew D ^a   Harmsen, William S ^a   Larson Keller, Jeffrey J ^a   Ilstrup, Duane M ^a   Keating, Michael R ^a   Wiesner, Russell H ^a   Krom, Ruud A F ^a   Paya, Carlos V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS; CANDIDIASIS; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; ESOPHAGITIS; FEMALE; HUMAN; INFECTION RISK; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RHIZOPUS; RISK FACTOR; SINUSITIS; SURGICAL MORTALITY;

ANALYSIS OF VARIANCE; CANDIDIASIS; EVALUATION STUDIES; HUMANS; LIVER TRANSPLANTATION; MYCOSES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 10244243721     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199610150-00010     Document Type: Article

References (54)

1. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 677.
2. Paya CV, Hermans PE, Washington JA, et al. Incidence, distribution, and outcome of episodes of infections in 100 orthotopic liver transplantations. Mayo Clin Proc 1989; 64: 555.
3. Tollemar J, Ericzon B-G, Holmberg K, Andersson J. The incidence and diagnosis of invasive fungal infections in liver transplant recipients. Transplant Proc 1990; 22: 242.
4. Steffen R, Reinhartz O, Blumharrdt G, et al. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantation. Transpl Int 1994; 55: 101.
5. George DL, Arnow PM, Fox A, et al. Patterns of infections after pediatric liver transplantation. Am J Dis Child 1992; 146: 924.
6. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988; 67: 132.
7. Schroter GPJ, Hoelscher M, Putnam CW, Porter KA, Starzl TE. Fungus infections after liver transplantation. Ann Surg 1977; 186: 115.
8. Alexander JA, Brouillette DE, Chien M, et al. Infectious esophagitis following liver and renal transplantation. Dig Dis Sci 1988; 33: 1121.
9. Castaldo P, Stratta RJ, Wood P, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149.
10. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994; 19: S33.
11. Castaldo P, Stratta RJ, Wood RP, et al. Fungal disease in liver transplant recipients: a multivariate analysis of risk factors. Transplant Proc 1991; 23: 1517.
12. Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347.
13. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994; 170: 644.
14. Martinez AJ, Abdab-Barmada M. The neuropathology of liver transplantation: comparison of main complications in children and adults. Mod Pathol 1993; 6: 25.
15. Colonna JO, Winston DJ, Brill JE, et al. Infectious complications in liver transplantation. Arch Surg 1988; 123: 360.
16. Mora NP, Cofer JB, Soloman H, et al. Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc 1991; 23: 1528.
17. Barkhold L, Ericzon B-G, Tollemar J, et al. Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int 1993; 6: 77.
18. Tollemar J, Ericzon B-G, Barkholt L, et al. Risk factors for deep Candida infections in liver transplant recipients. Transplant Proc 1990; 22: 1826.
19. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
20. Peto R, Peto J. Asymptomatically efficient rank invariant procedures (with discussion). J R Stat Soc Ser B 1972; 135: 185.
21. Cox DR. Regression in models and life-tables (with discussion). J R Stat Soc Ser V 1972; 34: 187.
22. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980: 122.
23. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995; 20: 617.
24. Gorensek MJ, Carey WD, Washington JA, et al. Selective bowel decontamination with quinolones and nystatin reduces gramnegative and fungal infections in orthotopic liver transplant recipients. Cleve Clin J Med 1993; 60: 139.
25. Wiesner RH, Hermans PE, Rakela J, et al. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 1988; 45: 570.
26. Kusne S, Tobin D, Pasculle AW, Van Thiel DH, Ho M, Starzl TE. Candida carriage in the alimentary tract of liver transplant candidates. Transplantation 1994; 57: 398.
27. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995; 20: 1531.
28. Stone HH, Geheber CE, Kolb LD, Kitchens WR. Alimentary tract colonization by Candida albicans. J Surg Res 1973; 14: 273.
29. Stone HH, Kolb LD, Currie CA, Geheber CE, Cuzzell JZ. Candida sepsis: pathogenesis and principles of treatment. Ann Surg 1974; 179: 697.
30. Inoue S, Wirman JA, Alexander JW, Trocki O, Cardell RR. Candida albicans translocation across the gut mucosa following burn injury. J Surg Res 1988; 44: 479.
31. Ruskin JD, Wood RP, Bailey MR, Whitmore CK, Shaw BW. Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. Oral Surg Oral Med Oral Pathol 1992; 74: 567.
32. Van der Waaij D, Vossen JM, Hartgrink CA, Nieweg HO. Polyene antibiotics in the prevention of Candida albicans colonization in the digestive tract of patients with severely decreased resistance to infections. In: Van der Waaij D, Verhoef J, eds. New criteria for antimicrobial therapy: maintenance of digestive tract colonization resistance. Amsterdam: Excerpta Medica, 1979: 135.
33. Wade JC, Schimpff SC, Hargadon MT, Fortner CL, Young VM, Wiernik PH. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 1981; 304: 1057.
34. Schimpff SC, Greene WH, Young VM, et al. Infection prevention in acute nonlymphocytic leukemia: laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 1975; 82: 351.
35. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patients. Intensive Care Med 1984; 10: 185.
36. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985; 5: 463.
37. Paya CV, Hermans PE. Bacterial infections after liver transplantation. Eur J Clin Microbiol Infect Dis 1989; 8: 499.
38. Hoe NY, Herman KJ, Hermann RE, Medendorp SV. Perioperative blood transfusion and survival of breast cancer patients after modified radical mastectomy. Cleve Clin J Med 1991; 58: 515.
39. Peller S, Sayfan J, Levy Y, et al. Immunological profile changes following perioperative autologous vs. homologous blood transfusion in oncologic patients. J Oncol Surg 1994; 56: 98.
40. Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and primary immunosuppression. Transplantation 1995; 59: 851.
41. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118: 173.
42. Paya CV, Hermans PE, Smith TF, et al. Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infections. Transplantation 1988; 46: 229.
43. Singh N, Mieles L, Yu VL, Gayowski T. Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low dose amphotericin B. Clin Infect Dis 1993; 17: 906.
44. Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognized complication of acute liver failure. J Hepatol 1991; 12: 1.
45. Walsh TJ, Hamilton SR. Disseminated aspergillosis complicating hepatic failure. Arch Intern Med 1983; 143: 1189.
46. Triger DR, Goepel JR, Slater DN, Underwood JCE. Systemic candidiasis complicating acute hepatic failure in patients treated with cimetidine. Lancet 1981; 2: 837.
47. Rossetti F, Brawner DL, Bowden R, et al. Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features. Clin Infect Dis 1995; 20: 801.
48. Canales J, Gove CD, Gimson AES, et al. Reticuloendothelial system and hepatocyte function in fulminant hepatic failure. Gut 1982; 23: 265.
49. Imawari M, Hughes RD, Gove CD, Williams R. Fibronectin and Kupffer cell function in fulminant hepatic failure. Dig Dis Sci 1985; 30: 1028.
50. Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol 1993; 18: 185.
51. Paya CV. Opportunistic infections: risk factor or virus-associated complication? Transplant Proc 1994; 26 (suppl 1): 12.
52. Mora NP, Klintman G, Soloman H, et al. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc 1992; 24: 154.
53. Tollemar J, Hockerstedt K, Ericzon V-G, Sundberg B, Ringden O. Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double blind studies. Transplant Proc 1994; 26: 1833.
54. Tollemar J, Hockerstedt K, Ericzon B-G, Jalanko H, Ringden O. Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial. Transplant Proc 1995; 27: 1195.